121 related articles for article (PubMed ID: 24200756)
21. Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on value.
Ollendorf DA; Migliaccio-Walle K; Colby JA; Pearson SD
J Comp Eff Res; 2013 May; 2(3):261-71. PubMed ID: 24236625
[TBL] [Abstract][Full Text] [Related]
22. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression.
Kozel FA; George MS; Simpson KN
CNS Spectr; 2004 Jun; 9(6):476-82. PubMed ID: 15162090
[TBL] [Abstract][Full Text] [Related]
23. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
24. [Repetitive transcranial magnetic stimulation in major depression: response factor].
Dumas R; Padovani R; Richieri R; Lançon C
Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
[TBL] [Abstract][Full Text] [Related]
25. Treatment-resistant depression in adolescents: review and updates on clinical management.
Maalouf FT; Atwi M; Brent DA
Depress Anxiety; 2011 Nov; 28(11):946-54. PubMed ID: 21898710
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based options for treatment-resistant adult bipolar disorder patients.
Poon SH; Sim K; Sum MY; Kuswanto CN; Baldessarini RJ
Bipolar Disord; 2012 Sep; 14(6):573-84. PubMed ID: 22938165
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan.
Noda Y; Miyashita C; Komatsu Y; Kito S; Mimura M
Psychiatry Res; 2023 Dec; 330():115573. PubMed ID: 37939593
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence.
Aarre TF; Dahl AA; Johansen JB; Kjønniksen I; Neckelmann D
Nord J Psychiatry; 2003; 57(3):227-32. PubMed ID: 12775299
[TBL] [Abstract][Full Text] [Related]
29. A Non-inferiority Framework for Cost-Effectiveness Analysis.
Xie X; Falk L; Brophy JM; Tu HA; Guo J; Gajic-Veljanoski O; Sikich N; Dhalla IA; Ng V
Int J Technol Assess Health Care; 2019; 35(4):291-297. PubMed ID: 31337452
[TBL] [Abstract][Full Text] [Related]
30. Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression.
Chatterton ML; Lee YY; Le LK; Nichols M; Carter R; Berk M; Mihalopoulos C
J Affect Disord; 2024 Jul; 356():639-646. PubMed ID: 38657770
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options in treatment-resistant depression.
Vieta E; Colom F
Ann Med; 2011 Nov; 43(7):512-30. PubMed ID: 21623700
[TBL] [Abstract][Full Text] [Related]
32. High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial.
Berlim MT; McGirr A; Beaulieu MM; Turecki G
J Affect Disord; 2011 Apr; 130(1-2):312-7. PubMed ID: 21056475
[TBL] [Abstract][Full Text] [Related]
33. [A new method for the treatment of depression: repetitive transcranial magnetic stimulation].
Cordes J; Mobascher A; Arends M; Agelink MW; Klimke A
Dtsch Med Wochenschr; 2005 Apr; 130(14):889-92. PubMed ID: 15800823
[TBL] [Abstract][Full Text] [Related]
34. The role of Transcranial Magnetic Stimulation in treatment resistant depression.
Rosser A; Warncken D; Mohan T; Bastiampillai T
Aust N Z J Psychiatry; 2015 May; 49(5):484. PubMed ID: 25526939
[No Abstract] [Full Text] [Related]
35. Resistant bipolar depressive disorder: case analysis of adjunctive transcranial magnetic stimulation efficiency in medical comorbid conditions.
Zendjidjian XY; Lodovighi MA; Richieri R; Guedj E; Boyer L; Dassa D; Lançon C
Bipolar Disord; 2014 Mar; 16(2):211-3. PubMed ID: 24350675
[No Abstract] [Full Text] [Related]
36. [Chronic depression--epidemiological data and therapeutic options].
Schüle C
Fortschr Neurol Psychiatr; 2014 Mar; 82(3):155-71; quiz 172-3. PubMed ID: 24615587
[No Abstract] [Full Text] [Related]
37. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
[TBL] [Abstract][Full Text] [Related]
38. Impact of drug treatment history on comparative effectiveness research in schizophrenia.
McCombs J; Zolfaghari S; Ganapathy V
Value Health; 2011; 14(5):679-86. PubMed ID: 21839406
[TBL] [Abstract][Full Text] [Related]
39. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
Berlim MT; Van den Eynde F; Daskalakis ZJ
J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
[TBL] [Abstract][Full Text] [Related]
40. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
